secwatch.observer — SEC 8-K summary
======================================

Issuer:     BAXTER INTERNATIONAL INC (BAX)
CIK:        0000010456
Form:       8-K
Filed at:   2022-10-27T23:59:59+00:00
Accession:  0001628280-22-027148
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Baxter reports Q3 GAAP loss of $5.83/share on $3.1B Hillrom impairment; adjusted EPS $0.82
--------------------------------------------------------------------------------

- Revenue $3.8B, up 17% reported, 23% constant currency, slightly positive operationally.
- GAAP net loss $2.9B ($5.83/share) driven by $3.1B pre-tax impairment of Hillrom goodwill and intangibles.
- Adjusted EPS $0.82, down 20% YoY; full-year adjusted EPS guidance set at $3.53 to $3.60.
- U.S. sales $1.8B (+40% reported, -1% operational); International $1.9B (+1% reported, +2% operational).
- FDA classified Ahmedabad manufacturing site as VAI (compliant), enabling new drug product approvals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10456/000162828022027148/0001628280-22-027148-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10456/000162828022027148/bax-20221027.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-027148

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer